arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BECTON DICKINSON & CO

BDX
$176.88 ▼ -0.26 (-0.15%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
74 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

BECTON DICKINSON & CO shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $49.6B
Dividend Yield 0.59%
Revenue Growth -10.6%
Op. Margin 2.0%
ROIC -0.2%
FCF / Share None
Trailing P/E
Price / Book 2.1x
FCF Yield
Debt / Equity 0.61
info Valuation on last close. End-of-day price, Aug 7, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$4.71B
↓ -10.6%
Net Income Profit after all expenses
$-311.00M
↓ -181.4%
Operating Margin Operating profit as % of sales
2.0%
↓ -81.2% 60th
FCF / Share Free cash flow per share
$1.92
↑ +23.5%
Long-Term Debt Long-term obligations
$14.71B
↓ -13.1%

Health Breakdown

Profitability
60
Returns
58
Financial Health
55

Dividend History

Dividend / share · sourced from SEC filings
$4.16 Latest / share
+9.5% YoY
+6.1% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters